
News|Articles|January 1, 2002
Acute migraine therapy: Triptan quantity limit maintains total health care savings 1 year out
Prime Therapeutics, St. Paul, MN-Do quantity limits on abortive migraine medications (ie, triptans) and educational efforts to increase the use of prophylactic therapy reduce total health care costs over the long term?
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New Therapies Targeting OX40 Pathway Offer Hope for Atopic Dermatitis | Fall Clinical Derm 2025
2
Shawn Kwatra, M.D. Highlights Challenges in Treating Complex Skin Conditions | Fall Clinical Derm 2025
3
Zoryve Cream Improves Sleep in Atopic Dermatitis Patients | Fall Clinical Derm 2025
4
1 in 10 U.S. Adults Have Physician-Diagnosed Chronic Hand Eczema, Study Shows | Fall Clinical Derm 2025
5


















































